Valuation: Camurus AB

Market Cap 37.16B 3.92B 3.36B 3.15B 2.88B 5.4B 375B 5.48B 14.49B 189B 14.74B 14.42B 624B P/E 2026 *
38.8x
P/E 2027 * 25.2x
Enterprise Value 32.65B 3.45B 2.95B 2.76B 2.53B 4.75B 330B 4.81B 12.73B 166B 12.95B 12.66B 548B EV / Sales 2026 *
11.4x
EV / Sales 2027 * 8.37x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day-0.87%
1 week-1.58%
Current month+1.13%
1 month+0.89%
3 months+16.51%
6 months+17.28%
Current year+1.38%
1 week 608.5
Extreme 608.5
644.5
1 month 586.5
Extreme 586.5
644.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 279.2
Extreme 279.2
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 31/12/2002
Director of Finance/CFO 57 30/06/2025
Chief Tech/Sci/R&D Officer 58 31/12/2024
Director TitleAgeSince
Director/Board Member 63 31/12/2001
Chairman 77 31/12/2014
Director/Board Member 61 06/05/2020
Date Insider Type Main position Quantity % Market Cap.
07/08/26 Sell

Executive/Senior Manager

-5,800 0.0096%
27/02/26 Sell

Chief Executive Officer

55,550 0.0928%
27/02/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
-0.87%-1.58%-7.62%+114.90% 3.96B
+0.88%+6.38%+76.86%+128.23% 1,109B
+1.07%+3.80%+51.03%+61.48% 644B
+1.20%+6.21%+26.47%+76.45% 463B
+1.02%+3.67%+43.14%+47.27% 371B
+0.85%+2.97%+24.48%+42.54% 301B
+1.26%+4.54%+2.20%+14.84% 256B
+1.88%+5.81%+48.54%+68.52% 234B
+1.59%+0.87%-12.95%-51.91% 205B
+1.87%+5.61%+25.81%+92.42% 178B
Average +1.08%+3.61%+27.80%+59.47% 376.5B
Weighted average by Cap. +1.13%+4.47%+44.52%+72.69%

Financials

2026 *2027 *
Net sales 2.86B 302M 258M 242M 221M 415M 28.86B 421M 1.11B 14.5B 1.13B 1.11B 47.96B 3.75B 396M 339M 317M 290M 545M 37.87B 552M 1.46B 19.02B 1.49B 1.45B 62.92B
Net income 949M 100M 85.85M 80.33M 73.53M 138M 9.59B 140M 370M 4.82B 376M 368M 15.93B 1.45B 153M 131M 123M 113M 211M 14.67B 214M 566M 7.37B 576M 563M 24.38B
Net Debt -4.52B -477M -409M -382M -350M -657M -45.64B -665M -1.76B -22.93B -1.79B -1.75B -75.84B -5.81B -613M -525M -492M -450M -844M -58.67B -856M -2.26B -29.48B -2.3B -2.25B -97.49B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
21/08/26 SEK 624.50 -0.87% 47,395
20/08/26 SEK 630.00 -0.16% 61,987
19/08/26 SEK 631.00 +0.80% 32,445
18/08/26 SEK 626.00 +1.79% 42,427
17/08/26 SEK 615.00 -0.40% 49,709
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
624.50SEK
Average target price
793.00SEK
Spread / Average Target
+26.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock